ARTHUR PRZYBYL
CIK 1268135 · President and CEO · last filed 2020-04-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.96M
Companies
5
Total Filings
71
Lifetime Open-Market Net
-$15.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANIP | President and CEO | 192,424 | $77.72 | $14.96M | -$4.60M | 42 | 2020-04-08 |
| ANI PHARMACEUTICALS INC (FOLD) Delisted | President and CEO | 202,589 | $14.49 | $2.94M | -$10.31M | 19 | 2019-05-15 |
| ANI PHARMACEUTICALS INC (BPAX) Delisted | President and CEO | 327,748 | — | — | $0 | 2 | 2013-07-16 |
| AKORN INC (AKRX) Delisted | President, CEO | 850,445 | — | — | -$930.2K | 7 | 2009-01-02 |
| AKORN INC (AKN) Delisted | President, CEO | — | — | — | $0 | 1 | 2007-01-04 |
Recent Filings · Page 7 of 8
71 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-08-30 | ANIP | Mixed | −5,631 | -$39.9K | EDGAR |
| 2013-07-16 | ANI PHARMACEUTICALS INC (BPAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-06-21 | ANI PHARMACEUTICALS INC (BPAX) Delisted | Grant (A) | +1,966,489 | $0 | EDGAR |
| 2009-01-02 | AKORN INC (AKRX) Delisted | Exer (M) | — | -$254.7K | EDGAR |
| 2008-12-22 | AKORN INC (AKRX) Delisted | Exer (M) | +6,144 | -$12.8K | EDGAR |
| 2008-12-17 | AKORN INC (AKRX) Delisted | Exer (M) | +10,932 | -$19.8K | EDGAR |
| 2008-06-24 | AKORN INC (AKRX) Delisted | Sell (S) | −273,002 | -$930.2K | EDGAR |
| 2008-04-22 | AKORN INC (AKRX) Delisted | Tax (F) | −21,531 | -$108.3K | EDGAR |
| 2007-12-19 | AKORN INC (AKRX) Delisted | Exer (M) | +75,000 | $62.5K | EDGAR |
| 2007-04-24 | AKORN INC (AKRX) Delisted | Tax (F) | −43,062 | -$317.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.